232 results
Page 4 of 12
6-K
EX-99.1
4lq yvict11vx
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
6-K
EX-99.1
lnf2 hwueeswo2akr
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
424B5
pr6cy5hx
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.1
kpzxa1gmggrer5
8 May 23
Report of Foreign Private Issuer
8:23am
6-K
EX-99.1
dbi76l70l67xfwgzx
2 May 23
SciSparc Completed Treatment of Last Patient Enrolled for its Phase IIa Clinical Trial for Alzheimer’s Disease and Agitation
7:28am
6-K
EX-99.1
19y6l206yrnkgm8per
4 Apr 23
SciSparc Receives Final Approval to Commence its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome
5:48pm
6-K
EX-99.1
90ou2 diix
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
EX-99.2
mc9l89
29 Dec 22
Interim Consolidated Financial Statements
4:03pm
6-K
EX-99.1
ppy lxinls
14 Dec 22
SciSparc Enters Into Non-Binding Letter of Intent to Sell a 50% interest in its Subsidiary that Owns an Amazon Top Seller Brand
4:01pm
6-K
EX-99.1
a15zx24v0h820j
7 Dec 22
SciSparc Announces Positive Study Results with SCI-210, a Cannabidiol-Based Treatment for Epilepsy
1:08pm
6-K
EX-99.1
129bojfk1zql
16 Nov 22
SciSparc Enters Into Letter of Intent with an E-commerce Company to Establish a Joint Venture to Market and Develop a New Product Line
4:02pm
6-K
EX-99.1
v3kd0x57uiltohjc02x
8 Nov 22
SciSparc Announced Positive Interim Results Meeting Primary Endpoints at Phase IIa Study in Alzheimer’s Disease Patients with Agitation
7:33am
6-K
EX-99.2
b0hhh
1 Nov 22
Since launch the new product has had approximately 117% ROI
4:00pm
6-K
EX-99.1
3zu4z6 gr76tfxrkgo7
1 Nov 22
Since launch the new product has had approximately 117% ROI
4:00pm
6-K
EX-99.1
2o126ze ziwtl66l0d2g
12 Oct 22
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
9:05am
6-K
EX-99.1
qv6urz dywg
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.6
k5vvd1 apk8gjbk9
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.5
7bn 3hmn29oec6
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.3
gw6b4ia
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am